2 unknown, 1 completed, 1 not yet recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Chronic Hemolysis: new trials by email Literature Review of Chronic Hemolysis trials Research Report on Chronic Hemolysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Development of an Innovative Hemodialysis Method to Improve Dialytic Clearance of Protein-bound Uremic Toxins Medialipide 20% perfusion, NaCl 0,9%, Blood sample - End Stage Renal Disease, Chronic Hemolysis | Phase 2 | Not yet recruiting | Hospices Civils de Lyon | 12 | 2025-01-01 | 2024-09-19 |
| Water Soluble Vitamins and Trace Elements Loss in Hemodiafiltration Patients Water-soluble vitamins and trace elements measures - Chronic Hemolysis | Completed | Hospices Civils de Lyon | 39 | 2021-07-19 | 2022-05-05 | |
| Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA Decrease per-dialytic heparin therapy - Chronic Hemolysis, VKA | Not applicable | Unknown | CHU de Reims | 49 | 2020-08-01 | 2020-07-08 |
| An Open Label Study of the Effects of Eculizumab in CD59 Deficiency Eculizumab - Chronic Hemolysis | Phase 1 / Phase 2 | Unknown | Hadassah Medical Organization | 5 | 2012-02-01 | 2012-04-18 |
Kidney Failure, Chronic (1) · Renal Insufficiency (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Chronic Disease (1) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
Blood Specimen Collection (1) · Perfusion (1) · eculizumab (1)
Hospices Civils de Lyon (2) · CHU de Reims (1) · Hadassah Medical Organization (1)
France (3) · Israel (1)
2023 (1)